Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Stomach Neoplasms 2Pancreatic Neoplasms 2Nasopharyngeal Carcinoma 2Colorectal Neoplasms 2Urinary Bladder Neoplasms 1Tumor Response Rate 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Radiation Injuries 1Prostatic Neoplasms 1Ovarian Neoplasms 1Ototoxicity 1Obesity 1Neurotoxicity Syndromes 1Neoplasm Metastasis 1Melanoma 1Liver Neoplasms 1Head and Neck Neoplasms 1Fatigue 1Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Sirtuins 1Radiotherapy, Conformal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Tumor Response Rate × Radiotherapy, Conformal × Clear all
NCT03910140 2019-04-10

TILA-TACE in Treatment of Hepatocellular Carcinoma

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase NA Unknown
2,000 enrolled

Tumor Response Rate

Data powered by HemOnc (CC BY 4.0) Colophon âš¡